DEPDC1 is abnormally over-expressed in the prostate, hepatic, breast, and lung cancers, according to recent research, and can predict outcomes in lung and bladder cancer patients (9–12). The gene discussed is DEPDC1; the disease is urinary bladder carcinoma.